NVST

Envista Holdings Corp
NYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$4.44B
P/E Ratio
48.49
EPS
$0.57
Beta
0.86
52W High
$30.42
52W Low
$18.77
50-Day MA
$26.43
200-Day MA
$24.74
Dividend Yield
Profit Margin
3.33%
Forward P/E
20.33
PEG Ratio

About Envista Holdings Corp

Envista Holdings Corporation, develops, manufactures and markets dental products in the United States and internationally. The company is headquartered in Brea, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$2.86B
Gross Profit (TTM)$1.60B
EBITDA$418.80M
Operating Margin12.10%
Return on Equity3.06%
Return on Assets3.37%
Revenue/Share (TTM)$17.41
Book Value$18.90
Price-to-Book1.47
Price-to-Sales (TTM)1.55
EV/Revenue1.74
EV/EBITDA11.81
Quarterly Earnings Growth (YoY)111.30%
Quarterly Revenue Growth (YoY)7.10%
Shares Outstanding$160.62M
Float$159.89M
% Insiders0.50%
% Institutions120.94%

Historical Volatility

HV 10-Day
36.20%
HV 20-Day
34.33%
HV 30-Day
33.43%
HV 60-Day
31.55%
HV Rank
40.9%

Volatility is currently expanding

Analyst Ratings

Consensus ($30.57 target)
1
Strong Buy
6
Buy
9
Hold

Latest News

Here's Why Envista (NVST) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research8/17/2026Positive
NVST vs. ABT: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research8/7/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NVST and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026